C Hershko1, A M Konijn, G Link. Show Affiliations » 1. Department of Medicine, Shaare Zedek Medical Centre, Jerusalem, Israel.
Abstract
Entities: Chemical
Mesh: See more » Administration, OralAza Compounds/therapeutic useChelating Agents/therapeutic useDeferiproneDeferoxamine/therapeutic useEdetic Acid/analogs & derivativesEdetic Acid/therapeutic useHumansIron/metabolismIron Chelating Agents/therapeutic useIron Overload/drug therapyIron Overload/etiologyLong-Term CarePyridones/therapeutic useThalassemia/drug therapyThalassemia/metabolism
Substances: See more » Aza CompoundsChelating AgentsIron Chelating AgentsPyridonesDeferiproneN,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acidEdetic AcidIronDeferoxamine
Year: 1998 PMID: 9633877 DOI: 10.1046/j.1365-2141.1998.00726.x
Source DB: PubMed Journal: Br J Haematol ISSN: 0007-1048 Impact factor: 6.998